Ketamine for Cancer-Related Pain in Palliative Care: A Systematic Review of Clinical Use and Safety.

J Pain Palliat Care PharmacotherJul 11, 2026 (epub)
Clinical ResearchOncology (Medical)

Catarina Vitorino-Afonso, Paulo Reis-Pina

✦ AI-curated · Sources linked

Condensed from the publisher's abstract. An xxcode editorial summary of this publication has not been generated yet.

From the abstract

Ketamine has emerged as an adjuvant for opioid-refractory cancer-related pain in palliative care, but evidence remains limited. This systematic review examined ketamine use for cancer-related pain in palliative and end-of-life care. MEDLINE, Cochrane Library, Web of Science, and Scopus were searched for English-language studies (publication 2017-2025).

Source

Published in J Pain Palliat Care Pharmacother. The text above is extracted from the publisher's own abstract and has not been edited by xxcode. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.